ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

ClinicalTrials.gov ID: NCT05014672

Public ClinicalTrials.gov record NCT05014672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TRANSFORM: A 24-week, Randomized, Placebo-controlled, Double-blind, Phase 2b Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness

Study identification

NCT ID
NCT05014672
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Calliditas Therapeutics Suisse SA
Industry
Enrollment
76 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Setanaxib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2022
Primary completion
May 30, 2024
Completion
Jul 1, 2024
Last update posted
Apr 23, 2025

2022 – 2024

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
UA Thomas D. Boyer Liver Institute Tucson Arizona 85724
Cedars-Sinai Medical Center Los Angeles California 90048
California Liver Research Institute Pasadena California 91105
University of California Davis Medical Center Sacramento California 95817
Gastroenterology Associates - Crystal River Inverness Florida 34452
University of Miami Leonard M. Miller School of Medicine Miami Florida 33136
AdventHealth Transplant Institute Orlando Florida 32804
Advanced Research Institute, Inc. Orlando Florida 32825
Tampa General Hospital Tampa Florida 33606
Northwestern University Evanston Illinois 60611
Springfield Clinic Springfield Illinois 62794-9248
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Kansas Medical Clinic - Gastroenterology Topeka Kansas 66606
Tulane Medical Center New Orleans Louisiana 70112
A. Alfred Taubman Health Care Center Ann Arbor Michigan 48109
Henry Ford Hospital Detroit Michigan 48202
Summit - Southern Therapy and Advanced Research Jackson Mississippi 39216
Northwell Health Manhasset New York 11030
New York University Hepatology Associates New York New York 10016
Icahn School of Medicine at Mount Sinai New York New York 10029
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
University of Cincinnati Cincinnati Ohio 45267-0595
Einstein Medical Center Philadelphia Pennsylvania 19141
Rapid City Medical Center Rapid City South Dakota 57701
Vanderbilt Digestive Disease Center Nashville Tennessee 37232
Liver Specialists of Texas Houston Texas 77030
Pioneer Research Solutions Houston Texas 77099
University of Utah Hospital Salt Lake City Utah 84132
Froedtert and Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05014672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05014672 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →